Prezcobix™ (darunavir / cobicistat) for the Treatment of HIV-1

Prezcobix™ (darunavir / cobicistat), discovered and developed by Janssen Therapeutics, is a fixed-dose antiretroviral combination tablet indicated for the treatment of human immunodeficiency virus (HIV-1) infection.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news